Filing metadata

Accession number
0001209191-23-006051
Form type
Form 4
Filer
ENDRA Life Sciences Inc.
CIK
CIK 1681682
Filed
Feb 01, 2023
Reporting period
Jan 30, 2023
Description
Insider transaction

Explore SEC Filings Hub